SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SYNPO2 promotes the development of BLCA by upregulating the infiltration of resting mast cells and increasing the resistance to immunotherapy

Published:2023-11-29 Issue:1 Volume:51 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Ye Gongjie¹,Tu Linglan²,Li Zhuduo²,Li Xiangyu²,Zheng Xiaoliang²,Song Yongfei³

Affiliation:

1. Department of Critical Care Medicine, Ningbo University, Ningbo, Zhejiang 315040, P.R. China

2. School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang 310012, P.R. China

3. Ningbo Institute of Innovation for Combined Medicine and Engineering, Ningbo Medical Centre Lihuili Hospital, Ningbo University, Ningbo, Zhejiang 315040, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference55 articles.

1. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

2. Advances in bladder cancer biology and therapy;Tran;Nat Rev Cancer,2021

3. Bladder cancer;Lenis;JAMA,2020

4. Bacillus Calmette-Guérin immunotherapy for bladder cancer: A review of immunological aspects, clinical effects and BCG infections;Larsen;APMIS,2020

5. A systematic review and meta-analysis of radical cystectomy in the treatment of muscular invasive bladder cancer (MIBC);Zhao;Transl Androl Urol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive multi-omics analysis reveals the molecular mechanism of prostate cancer recurrence;2024-08-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP